Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-046905

Chief Scientific Officer sold 6,000 shares at $7.32 ($43,895)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2023-08-21 Sale 10b5-1 −6,000 $7.32 $43,895 135,724 D
Open-market sales · 6,000 sh · avg $7.32 · $43,895
Loading xslF345X05/doc4.xml…